Association of Oncogenic Mutations in Advanced cSCC Treated With Cetuximab

This study examines the association of HRAS, KRAS, NRAS, BRAF, and EGFR mutations in 31 patients with advanced cutaneous squamous cell carcinomas treated with cetuximab.

http://ift.tt/2mPgf6Z